This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1vkt

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Functional surfaces of a protein are often mapped by combination of X-ray, crystallography and mutagenesis. Such studies of insulin have yielded, paradoxical results, suggesting that the native state is inactive and, reorganizes on receptor binding. Of particular interest is the N-terminal, alpha-helix of the A-chain. Does this segment function as an alpha-helix, or reorganize as recently proposed in a prohormone-convertase complex? To, correlate structure and function, we describe a mapping strategy based on, protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template, for synthesis of a novel A-chain analogue. Designed by analogy to a, protein-folding intermediate, the analogue lacks the A6-A11 disulphide, bridge; the cysteine residues are replaced by serine. Its solution, structure is remarkable for segmental unfolding of the N-terminal A-chain, alpha-helix (A1 to A8) in an otherwise native subdomain. The structure, demonstrates that the overall orientation of the A and B chains is, consistent with reorganization of the A-chain's N-terminal segment., Nevertheless, the analogue's low biological activity suggests that this, segment, a site of clinical mutation causing diabetes mellitus, functions, as a preformed recognition alpha-helix.
+
Functional surfaces of a protein are often mapped by combination of X-ray crystallography and mutagenesis. Such studies of insulin have yielded paradoxical results, suggesting that the native state is inactive and reorganizes on receptor binding. Of particular interest is the N-terminal alpha-helix of the A-chain. Does this segment function as an alpha-helix or reorganize as recently proposed in a prohormone-convertase complex? To correlate structure and function, we describe a mapping strategy based on protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template for synthesis of a novel A-chain analogue. Designed by analogy to a protein-folding intermediate, the analogue lacks the A6-A11 disulphide bridge; the cysteine residues are replaced by serine. Its solution structure is remarkable for segmental unfolding of the N-terminal A-chain alpha-helix (A1 to A8) in an otherwise native subdomain. The structure demonstrates that the overall orientation of the A and B chains is consistent with reorganization of the A-chain's N-terminal segment. Nevertheless, the analogue's low biological activity suggests that this segment, a site of clinical mutation causing diabetes mellitus, functions as a preformed recognition alpha-helix.
==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Burke, G.T.]]
+
[[Category: Burke, G T.]]
-
[[Category: Chu, Y.C.]]
+
[[Category: Chu, Y C.]]
-
[[Category: Frank, B.H.]]
+
[[Category: Frank, B H.]]
-
[[Category: Hu, S.Q.]]
+
[[Category: Hu, S Q.]]
-
[[Category: Hua, Q.X.]]
+
[[Category: Hua, Q X.]]
-
[[Category: Jia, W.H.]]
+
[[Category: Jia, W H.]]
-
[[Category: Katsoyannis, P.G.]]
+
[[Category: Katsoyannis, P G.]]
-
[[Category: Wang, S.H.]]
+
[[Category: Wang, S H.]]
-
[[Category: Weiss, M.A.]]
+
[[Category: Weiss, M A.]]
[[Category: disulfide model]]
[[Category: disulfide model]]
[[Category: hormone]]
[[Category: hormone]]
[[Category: human insulin]]
[[Category: human insulin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:05:08 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:36:22 2008''

Revision as of 13:36, 21 February 2008


1vkt

Drag the structure with the mouse to rotate

HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES

Contents

Overview

Functional surfaces of a protein are often mapped by combination of X-ray crystallography and mutagenesis. Such studies of insulin have yielded paradoxical results, suggesting that the native state is inactive and reorganizes on receptor binding. Of particular interest is the N-terminal alpha-helix of the A-chain. Does this segment function as an alpha-helix or reorganize as recently proposed in a prohormone-convertase complex? To correlate structure and function, we describe a mapping strategy based on protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template for synthesis of a novel A-chain analogue. Designed by analogy to a protein-folding intermediate, the analogue lacks the A6-A11 disulphide bridge; the cysteine residues are replaced by serine. Its solution structure is remarkable for segmental unfolding of the N-terminal A-chain alpha-helix (A1 to A8) in an otherwise native subdomain. The structure demonstrates that the overall orientation of the A and B chains is consistent with reorganization of the A-chain's N-terminal segment. Nevertheless, the analogue's low biological activity suggests that this segment, a site of clinical mutation causing diabetes mellitus, functions as a preformed recognition alpha-helix.

Disease

Known diseases associated with this structure: Diabetes mellitus, rare form OMIM:[176730], Hyperproinsulinemia, familial OMIM:[176730], MODY, one form OMIM:[176730]

About this Structure

1VKT is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue., Hua QX, Hu SQ, Frank BH, Jia W, Chu YC, Wang SH, Burke GT, Katsoyannis PG, Weiss MA, J Mol Biol. 1996 Nov 29;264(2):390-403. PMID:8951384

Page seeded by OCA on Thu Feb 21 15:36:22 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools